Recent trading patterns in Manulife stock price forecast suggest resistance near CAD 29.20, with institutional buying signaling confidence in long-term earnings stability despite short-term volatility in global equities. This recent development has the potential to bolster revenue and earnings forecasts by leveraging the growing interest in diversified real asset exposure, which aligns well with Manulife's strategic focus areas. Analysts expect Manulife's revenue to grow by 20.9% annually over the next three years, driven by these strategic initiatives. Yet, the stock currently trades at CA$42.87, slightly below the consensus analyst price target of CA$47.69. If the company achieves the projected revenue growth and earnings expectations, it could align more closely with its forward price target, potentially narrowing the discount of approximately 10.8% to the analyst target. In terms of valuation , Manulife tends to trade at lower multiples compared to Sun Life. This could present an attractive entry point for value-focused investors. However, it’s essential to consider the growth trajectories and challenges each company faces. Analyst sentiments also provide some insights. For Sun Life, the average 12-month stock price forecast is $87, with a high estimate of $94 and a low of $75. This suggests a potential upside of approximately 9.89% based on current prices. Manulife stock price forecast shows moderate upside potential as analysts project a 12-month target range between CAD 27.50 and CAD 30.00, supported by steady insurance premium growth and diversified asset management revenues.
